Literature DB >> 17660321

Mechanism of islet amyloid polypeptide fibrillation at lipid interfaces studied by infrared reflection absorption spectroscopy.

D H J Lopes1, A Meister, A Gohlke, A Hauser, A Blume, R Winter.   

Abstract

Islet amyloid polypeptide (IAPP) is a pancreatic hormone and one of a number of proteins that are involved in the formation of amyloid deposits in the islets of Langerhans of type II diabetes mellitus patients. Though IAPP-membrane interactions are known to play a major role in the fibrillation process, the mechanism and the peptide's conformational changes involved are still largely unknown. To obtain new insights into the conformational dynamics of IAPP upon its aggregation at membrane interfaces and to relate these structures to its fibril formation, we studied the association of IAPP at various interfaces including neutral as well as charged phospholipids using infrared reflection absorption spectroscopy. The results obtained reveal that the interaction of human IAPP with the lipid interface is driven by the N-terminal part of the peptide and is largely driven by electrostatic interactions, as the protein is able to associate strongly with negatively charged lipids only. A two-step process is observed upon peptide binding, involving a conformational transition from a largely alpha-helical to a beta-sheet conformation, finally forming ordered fibrillar structures. As revealed by simulations of the infrared reflection absorption spectra and complementary atomic force microscopy studies, the fibrillar structures formed consist of parallel intermolecular beta-sheets lying parallel to the lipid interface but still contain a significant number of turn structures. We may assume that these dynamical conformational changes observed for negatively charged lipid interfaces play an important role as the first steps of IAPP-induced membrane damage in type II diabetes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17660321      PMCID: PMC2025658          DOI: 10.1529/biophysj.107.110635

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  65 in total

Review 1.  Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology.

Authors:  E T Jaikaran; A Clark
Journal:  Biochim Biophys Acta       Date:  2001-11-29

2.  Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.

Authors:  Rakez Kayed; Elizabeth Head; Jennifer L Thompson; Theresa M McIntire; Saskia C Milton; Carl W Cotman; Charles G Glabe
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

Review 3.  Pancreatic islet amyloid in type 2 diabetes mellitus: a clinical and historical review.

Authors:  M R Hayden
Journal:  Mo Med       Date:  2002 Sep-Oct

4.  Human amylin oligomer growth and fibril elongation define two distinct phases in amyloid formation.

Authors:  Janelle D Green; Claire Goldsbury; Joerg Kistler; Garth J S Cooper; Ueli Aebi
Journal:  J Biol Chem       Date:  2004-01-01       Impact factor: 5.157

5.  The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies.

Authors:  Yair Porat; Sofiya Kolusheva; Raz Jelinek; Ehud Gazit
Journal:  Biochemistry       Date:  2003-09-23       Impact factor: 3.162

6.  Enhanced in vitro production of amyloid-like fibrils from mutant (S20G) islet amyloid polypeptide.

Authors:  Z Ma; G T Westermark; S Sakagashira; T Sanke; A Gustavsson; H Sakamoto; U Engström; K Nanjo; P Westermark
Journal:  Amyloid       Date:  2001-12       Impact factor: 7.141

7.  Fourier transform infrared spectroscopy provides a fingerprint for the tetramer and for the aggregates of transthyretin.

Authors:  Yraima Cordeiro; Julia Kraineva; Marisa Carvalho Suarez; Anna Gabriella Tempesta; Jeffery W Kelly; Jerson L Silva; Roland Winter; Debora Foguel
Journal:  Biophys J       Date:  2006-05-12       Impact factor: 4.033

Review 8.  Beta-amyloid production, aggregation, and clearance as targets for therapy in Alzheimer's disease.

Authors:  Fernanda G De Felice; Sérgio T Ferreira
Journal:  Cell Mol Neurobiol       Date:  2002-12       Impact factor: 5.046

9.  Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes.

Authors:  Magdalena Anguiano; Richard J Nowak; Peter T Lansbury
Journal:  Biochemistry       Date:  2002-09-24       Impact factor: 3.162

10.  The N-terminal repeat domain of alpha-synuclein inhibits beta-sheet and amyloid fibril formation.

Authors:  Jeffrey C Kessler; Jean-Christophe Rochet; Peter T Lansbury
Journal:  Biochemistry       Date:  2003-01-28       Impact factor: 3.162

View more
  46 in total

1.  Enrichment of amyloidogenesis at an air-water interface.

Authors:  Létitia Jean; Chiu Fan Lee; David J Vaux
Journal:  Biophys J       Date:  2012-03-06       Impact factor: 4.033

2.  Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane.

Authors:  Maarten F M Engel; Lucie Khemtémourian; Cécile C Kleijer; Hans J D Meeldijk; Jet Jacobs; Arie J Verkleij; Ben de Kruijff; J Antoinette Killian; Jo W M Höppener
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-11       Impact factor: 11.205

Review 3.  Membranes as modulators of amyloid protein misfolding and target of toxicity.

Authors:  Anoop Rawat; Ralf Langen; Jobin Varkey
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-04-25       Impact factor: 3.747

4.  Conformational Dynamics of the Human Islet Amyloid Polypeptide in a Membrane Environment: Toward the Aggregation Prone Form.

Authors:  Katrine Kirkeby Skeby; Ole Juul Andersen; Taras V Pogorelov; Emad Tajkhorshid; Birgit Schiøtt
Journal:  Biochemistry       Date:  2016-03-22       Impact factor: 3.162

5.  C4b-binding Protein Protects β-Cells from Islet Amyloid Polypeptide-induced Cytotoxicity.

Authors:  Jonatan Sjölander; Elin Byman; Klaudia Kulak; Sara C Nilsson; Enming Zhang; Ulrika Krus; Gunilla T Westermark; Petter Storm; Ben C King; Erik Renström; Anna M Blom
Journal:  J Biol Chem       Date:  2016-08-26       Impact factor: 5.157

6.  Structures of rat and human islet amyloid polypeptide IAPP(1-19) in micelles by NMR spectroscopy.

Authors:  Ravi Prakash Reddy Nanga; Jeffrey R Brender; Jiadi Xu; Gianluigi Veglia; Ayyalusamy Ramamoorthy
Journal:  Biochemistry       Date:  2008-12-02       Impact factor: 3.162

7.  Interaction of IAPP and insulin with model interfaces studied using neutron reflectometry.

Authors:  Christoph Jeworrek; Oliver Hollmann; Roland Steitz; Roland Winter; Claus Czeslik
Journal:  Biophys J       Date:  2009-02       Impact factor: 4.033

8.  Amyloidogenesis abolished by proline substitutions but enhanced by lipid binding.

Authors:  Ping Jiang; Weixin Xu; Yuguang Mu
Journal:  PLoS Comput Biol       Date:  2009-04-10       Impact factor: 4.475

9.  Lysophosphatidylcholine modulates the aggregation of human islet amyloid polypeptide.

Authors:  Yanting Xing; Emily H Pilkington; Miaoyi Wang; Cameron J Nowell; Aleksandr Kakinen; Yunxiang Sun; Bo Wang; Thomas P Davis; Feng Ding; Pu Chun Ke
Journal:  Phys Chem Chem Phys       Date:  2017-11-22       Impact factor: 3.676

10.  Amyloid formation in heterogeneous environments: islet amyloid polypeptide glycosaminoglycan interactions.

Authors:  Hui Wang; Ping Cao; Daniel P Raleigh
Journal:  J Mol Biol       Date:  2012-11-12       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.